Comparing Two Doses of Ipilimumab

Publication
Article
Special ReportsMelanoma (Issue 4)
Volume 4
Issue 1

Ahmad Tarhini, MD, PhD, associate professor, University of Pittsburgh School of Medicine, compares two doses of ipilimumab (Yervoy).

Ahmad Tarhini, MD, PhD, associate professor, University of Pittsburgh School of Medicine, compares two doses of ipilimumab (Yervoy).

<<<

Back to the Melanoma Special Report

Recent Videos
Michael B. Atkins, MD, an expert on melanoma
Michael B. Atkins, MD, an expert on melanoma
Related Content